New York Health Care, Inc. (the “Company”) (Nasdaq: BBAL - News) today announced financial results for the year-ended December 31, 2003. Net patient service revenues of $45,060,449 were entirely generated from its healthcare services business. The Company’s BioBalance subsidiary is a developmental stage specialty pharmaceutical company which did not generate revenues in 2003.
